NTRR Readies Solutions to Colorado's Crackdown on Cannabis Pesticides

TAMPA, Fla.--(BUSINESS WIRE)--

Neutra Corp. NTRR will complete market testing this week on a new suite of products that could help cannabis growers avoid Colorado's crackdown on pesticides.

A Colorado state Senate panel voted unanimously last week to give the state's Department of Agriculture the funds necessary to step up pesticide enforcement in the cannabis sector. Although the state already outlines which chemicals commercial growers may use on their crops, testing backlogs have kept requirements from being implemented.

Now, the state is changing its policy to eliminate that backlog, and NTRR will be ready with new products to help growers comply with state regulations, said NTRR CEO Chris Brown.

"We are very much looking forward to working with growers to help them produce top-notch crops that will comply with all of the state's shifting requirements," Brown said. "Alongside our joint venture partner, Surface to Air Solutions (S2O2), NTRR is bringing to market badly-needed pesticide alternatives that will help keep plants and surfaces free from contamination."

Last month, S2O2 submitted its products to be tested by a third-party lab at the indoor growing operations run by top producers DANK Dispensaries and Denver Consulting Group. By verifying these products' use in eliminating contaminants from cannabis, the joint venture plans to take the first step toward making them industry-standard across the entire regulated sector.

NTRR formed the joint venture with S2O2 last year to market solutions to growers that are concerned about contamination of their crops by microbes, molds, fungus and other pests.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals GWPRF, INSYS Therapeutics, Inc. INSY and ENDEXX Corp. EDXC, delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150519005767/en/